🔗 Share this article

The prestigious award in medical science has been granted for transformative findings that clarify how the immune system targets harmful infections while sparing the healthy tissues.

Three esteemed scientists—from Japan Prof. Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this honor.

Their work identified specialized "security guards" within the defense system that remove malfunctioning immune cells that could harming the body.

These findings are now paving the way for new treatments for autoimmune diseases and cancer.

These laureates will divide a prize fund valued at 11 million SEK.

Decisive Findings

"The work has been essential for comprehending how the immune system operates and the reason we do not all develop serious self-attack conditions," commented the chair of the award panel.

This trio's studies address a fundamental mystery: In what way does the defense system protect us from numerous infections while keeping our own tissues unharmed?

The immune system uses immune cells that scan for indicators of disease, including pathogens and germs it has not met before.

These defenders utilize sensors—called recognition units—that are generated by chance in a vast number of variations.

This gives the defense network the capacity to fight a broad range of threats, but the randomness of the process inevitably creates white blood cells that may attack the host.

Protectors of the Immune System

Scientists previously knew that some of these problematic white blood cells were eliminated in the thymus—where white blood cells mature.

The latest Nobel Prize honors the identification of regulatory T-cells—described as the body's "security guards"—which patrol the body to neutralize any immune cells that assault the healthy cells.

It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "The discoveries have laid the foundation for a novel area of research and spurred the creation of new treatments, for example for tumors and autoimmune diseases."

In malignancies, regulatory T-cells block the body from fighting the growth, so studies are focused on reducing their quantity.

In self-attack disorders, trials are exploring increasing regulatory T-cells so the organism is not under attack. A comparable method could also be effective in reducing the risks of transplanted organ rejection.

Pioneering Experiments

Professor Sakaguchi, from Osaka University, performed experiments on rodents that had their thymus extracted, leading to autoimmune disease.

The researcher demonstrated that introducing defense cells from healthy animals could prevent the disease—suggesting there was a mechanism for blocking defenders from attacking the host.

Mary Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in a California city, were investigating an inherited immune disorder in rodents and humans that resulted in the identification of a genetic factor vital for how regulatory T-cells operate.

"The pioneering work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," said a leading physiology specialist.

"This work is a striking illustration of how basic physiological research can have far-reaching consequences for human health."